| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 1/50-1/200 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | HDAC2; Histone deacetylase 2; HD2 |
| Entrez GeneID | 3066 |
| clone | 3G11 |
| WB Predicted band size | Calculated MW: 55 kDa; Observed MW: 60 kDa |
| Host/Isotype | Mouse IgG2b |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human,Mouse,Rat,Monkey |
| Immunogen | Purified recombinant human HDAC2 protein fragments expressed in E.coli. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide,0.5%BSA and 50% glycerol. |
+ +
以下是关于HDAC2抗体的3篇参考文献示例，涵盖其在不同研究中的应用和功能分析：
---
1. **文献名称**：*HDAC2 regulates synaptic plasticity and memory formation by deacetylating histone H3 in the hippocampus*
**作者**：Guan JS, et al.
**摘要**：该研究通过免疫组化和Western blot分析，利用HDAC2特异性抗体揭示了HDAC2在小鼠海马体突触可塑性和记忆形成中的作用，表明其通过组蛋白H3去乙酰化调控基因表达。
---
2. **文献名称**：*Selective inhibition of HDAC2 by small molecules alters chromatin remodeling and enhances neurogenesis*
**作者**：Ballas N, et al.
**摘要**：研究使用HDAC2抗体进行染色质免疫沉淀(ChIP)实验，证明选择性抑制HDAC2可促进神经干细胞分化和神经元生成，为神经退行性疾病治疗提供新靶点。
---
3. **文献名称**：*HDAC2 modulates TGF-β-mediated epithelial-mesenchymal transition in lung cancer cells*
**作者**：Ramakrishnan S, et al.
**摘要**：通过免疫荧光和免疫印迹技术，该文献发现HDAC2抗体检测到其在肺癌细胞中的高表达，并证实HDAC2通过调节TGF-β信号通路促进上皮-间质转化(EMT)，影响肿瘤转移。
---
以上文献均涉及HDAC2抗体的应用(如Western blot、免疫组化、ChIP等)，并探讨了其在表观遗传调控、疾病机制中的关键作用。如需具体文献来源(期刊、年份)，可进一步补充筛选。
Histone deacetylase 2 (HDAC2) is a member of the HDAC enzyme family, which plays a critical role in epigenetic regulation by removing acetyl groups from histone proteins. This activity promotes chromatin condensation, repressing gene transcription. HDAC2 is involved in diverse cellular processes, including cell cycle progression, differentiation, apoptosis, and DNA repair. Dysregulation of HDAC2 has been linked to cancer, neurodegenerative disorders (e.g., Alzheimer’s disease), and metabolic syndromes, making it a key target for therapeutic research.
HDAC2 antibodies are essential tools for studying its expression, localization, and function in biological systems. These antibodies are widely used in techniques like Western blotting, immunohistochemistry (IHC), immunofluorescence (IF), and chromatin immunoprecipitation (ChIP). Specificity and validation are crucial, as HDAC2 shares high homology with other class I HDACs (HDAC1. HDAC3. HDAC8). High-quality HDAC2 antibodies are often validated using knockout cell lines or siRNA-mediated knockdown to confirm target specificity. Researchers also utilize these antibodies to explore HDAC2's role in disease mechanisms or to evaluate the efficacy of HDAC inhibitors—a promising class of drugs in oncology and neurology. As HDAC2's context-dependent roles (e.g., tumor suppressor or promoter) continue to emerge, reliable antibodies remain vital for advancing both basic research and clinical applications.
×
